Media 2018-01-16T20:50:42+00:00


Pulmonary Fibrosis News – January, 2018

NuMedii Advances IPF Personalized Medicine with New Advisory Board to Guide AI Approach

Medical Device and Diagnostic Industry (MD+DI) – January, 2018

Sifting Nuggets of Truth out of the AI Hooplah

MedCity News – January, 2018

Andy Slavitt: When it comes to AI, it is the best of times, worst of times story

WuXi AppTec – October, 2017

Inside Perspectives: NuMedii Banking on Artificial Intelligence to Expedite the Discovery of Effective New Medicines

The Scientist – January, 2017

Repurposing Existing Drugs for New Indications


January 5, 2018

World’s Leading Lung Disease Experts Join NuMedii’s Idiopathic Pulmonary Fibrosis Advisory Board

April 11, 2017

NuMedii, Inc. Announces New Partnership To Discover And Advance New Treatments For Idiopathic Pulmonary Fibrosis

November 2, 2016

NuMedii, Inc. Wins 2016 Bioprocess International Award For Emerging Company

October 4, 2016

NuMedii, Inc. Announces Third Pharmaceutical Discovery Collaboration

January 11, 2016

NuMedii Announces New Indications Discovery Collaboration With Astellas

September 29, 2015

NuMedii Announces Research Collaboration With Allergan To Explore New Treatments For Psoriasis

August 8, 2015

NuMedii Supports California Precision Medicine Effort: Collaboration with California Kids Cancer Comparison Project Led by UC Santa Cruz Researchers

November 4, 2013

Thomson Reuters and NuMedii Launch Ground-Breaking Initiative to Identify Drugs for Repurposing

June 26, 2013

NuMedii Receives $3.5M in a Series A Financing From Claremont Creek Ventures and Lightspeed Venture Partners

October 3, 2012

NuMedii Announces Strategic Alliance with Aptalis


Check back for updates